Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Ropinirole as an effective adjunctive treatment for clozapine-resistant negative symptoms in simple schizophrenia: a case report.

Michalopoulou PG, Azim A, Tracy D, Shergill SS.

J Clin Psychopharmacol. 2012 Oct;32(5):719-20. doi: 10.1097/JCP.0b013e318267062c. No abstract available.

PMID:
22926612
2.

Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia.

al-Semaan Y.

Can J Psychiatry. 1996 Sep;41(7):484-5. No abstract available.

PMID:
8884041
3.

DAI-10 is as good as DAI-30 in schizophrenia.

Nielsen RE, Lindström E, Nielsen J, Levander S.

Eur Neuropsychopharmacol. 2012 Oct;22(10):747-50. doi: 10.1016/j.euroneuro.2012.02.008. Epub 2012 Mar 21.

PMID:
22440974
4.

Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.

Zink M, Mase E, Dressing H.

Hum Psychopharmacol. 2004 Jun;19(4):271-3.

PMID:
15181656
5.

Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?

Karunakaran K, Tungaraza TE, Harborne GC.

J Psychopharmacol. 2007 Jun;21(4):453-6. Epub 2006 Oct 18.

PMID:
17050662
6.

Addition of risperidone to clozapine therapy in chronically psychotic inpatients.

de Groot IW, Heck AH, van Harten PN.

J Clin Psychiatry. 2001 Feb;62(2):129-30. No abstract available.

PMID:
11247102
7.

Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.

Nielsen J, Emborg C, Gydesen S, Dybbro J, Aagaard J, Haderup K, Glyngdal P, Fabricius S, Thode D, Lublin H, Andersen T, Damkier P, Taylor D.

J Clin Psychopharmacol. 2012 Apr;32(2):173-8. doi: 10.1097/JCP.0b013e318248dfb8.

PMID:
22367659
8.

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B.

Am J Psychiatry. 1999 Jan;156(1):145-7.

PMID:
9892314
9.

Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?

Jiménez-Cornejo M, Munizaga G, Aceituno D.

Medwave. 2016 Dec 2;16(Suppl5):e6614. doi: 10.5867/medwave.2016.6614. Review. Spanish, English.

PMID:
27922589
10.

Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients.

Mowerman S, Siris SG.

Ann Clin Psychiatry. 1996 Dec;8(4):193-7.

PMID:
8986313
11.

Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies.

Lane HY, Chang WH.

J Clin Psychiatry. 1999 Jul;60(7):487-8. No abstract available.

PMID:
10453806
12.

Clozapine augmentation with aripiprazole for negative symptoms.

Clarke LA, Lindenmayer JP, Kaushik S.

J Clin Psychiatry. 2006 Apr;67(4):675-6. No abstract available.

PMID:
16669737
13.
14.

[Clozapine--the neglected potential].

Munitz H.

Harefuah. 2012 May;151(5):298-300, 318, 317. Review. Hebrew.

PMID:
22844735
15.

Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.

Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C.

World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):502-5. doi: 10.3109/15622970802269597.

PMID:
20218805
16.

Clozapine and excessive psychotropic drug use.

Drew LR, Minehan K, Cowley J.

Psychiatr Serv. 1996 Aug;47(8):876. No abstract available.

PMID:
8837165
17.

Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.

Cook B, Hoogenboom G.

Australas Psychiatry. 2004 Mar;12(1):74-6.

PMID:
15715745
18.

Clozapine induced akathisia: a case report and review of the evidence.

Grover S, Sahoo S.

Indian J Pharmacol. 2015 Mar-Apr;47(2):234-5. doi: 10.4103/0253-7613.153441.

19.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
20.

Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.

Ziegenbein M, Kropp S, Kuenzel HE.

Clin Neuropharmacol. 2005 Sep-Oct;28(5):220-4.

PMID:
16239761

Supplemental Content

Support Center